SIGMA Brand
Displaying 5401-5450 of 92621 results.
| Sigma Cat.No. | Description |
|---|---|
| B0555 | Anti-Vascular Endothelial Growth Factor Receptor-2 (KDR)−Biotin Conjugate antibody, Mouse monoclonal clone 260.4, KDR-2, purified from hybridoma cell culture |
| B0556 | Anti-B23 antibody, Mouse monoclonal clone FC82291, purified from hybridoma cell culture |
| B0560 | (−)-Blebbistatin solid, synthetic |
| B0631 | 5-Bromo-2′-deoxyuridine 5′-triphosphate sodium salt ≥90% |
| B0658 | Nalgene® centrifuge bottles, Style 3122 nominal capacity 500 mL |
| B0681 | Anti-BACE 1, N-Terminus (46-62) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| B0684 | Anti-Bad antibody produced in rabbit affinity isolated antibody, lyophilized powder |
| B0753 | 2,3-Butanedione monoxime ≥98% |
| B0908 | Nalgene® centrifuge bottles, Style 3122 nominal capacity 1000 mL |
| B0935 | Benazepril hydrochloride ≥98% (HPLC), solid |
| B0936 | BRL 50481 ≥98% (HPLC), solid |
| B0939 | BAFF active human Animal-component free, recombinant, expressed in Nicotiana, >97% (SDS-PAGE) |
| B102 | Bupropion hydrochloride ≥98% (HPLC), solid |
| B1022 | Biotinamidohexanoic acid 3- ≥90% (TLC), powder |
| B1033 | Nalgene® centrifuge bottles, style 3120 nominal capacity 250 mL |
| B1059 | Bcl-w (Minus C-Terminus) human >95% (SDS-PAGE), recombinant, expressed in E. coli, buffered aqueous glycerol solution |
| B1064 | Cibacron Blue 3G-A Dye content ≥55 % |
| B107 | L-BMAA hydrochloride ≥97% (NMR), powder |
| B112 | (±)-Bay K8644 calcium channel agonist |
| B1125 | Bathocuproinedisulfonic acid disodium salt for spectrophotometric det. of Cu, Fe |
| B1140 | Anti-Human IgG (γ-chain specific)-Biotin antibody produced in goat affinity isolated antibody, buffered aqueous solution |
| B1152 | Betamethasone 17,21-dipropionate |
| B1155 | bisBenzimide H 33258 powder, BioReagent, suitable for cell culture, ≥98% (HPLC and TLC) |
| B1185 | Bioreactor pH Adjustment Solution liquid, sterile-filtered, suitable for cell culture |
| B121 | Bromoacetylcholine bromide |
| B1265 | Anti-Human IgM (μ-chain specific)−Biotin antibody produced in goat affinity isolated antibody, buffered aqueous solution |
| B1267 | Biotin-maleimide ≥95% (TLC), powder |
| B1283 | Nalgene® centrifuge bottles, style 3120 nominal capacity 500 mL |
| B1310 | Anti-BACH1 antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| B133 | (S)-(−)-Bay K8644 ≥98% (HPLC), solid |
| B134 | BMY 7378 dihydrochloride ≥98% (HPLC), solid |
| B1375 | Bathophenanthrolinedisulfonic acid disodium salt hydrate ≥95% |
| B1379 | 5- sulfatase substrate |
| B1381 | 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt ≥98% (HPLC), powder |
| B1395 | Anti-Bovine IgG (whole molecule) antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution |
| B1401 | Bradykinin Fragment 1-5 ≥97% (HPLC) |
| B1403 | Boc-L-alaninal ≥98% |
| B1408 | Nalgene® centrifuge bottles, style 3120 nominal capacity 1000 mL |
| B1427 | H-89 dihydrochloride hydrate ≥98% (HPLC), powder |
| B1434 | Bone Morphogenetic Protein 7 human >95% (SDS-PAGE), recombinant, expressed in CHO cells, lyophilized powder, suitable for cell culture |
| B1436 | BAX Inhibiting Peptide V5 ≥97% (HPLC), lyophilized powder |
| B1439 | Brassinolide ≥80% (TLC) |
| B150 | BQ-123 ≥99%, sodium salt, lyophilized powder |
| B1502 | Brain Extract from bovine brain Type I, Folch Fraction I |
| B1508 | Butyryl coenzyme A lithium salt hydrate ≥90% |
| B1520 | Anti-Bovine Albumin antibody produced in rabbit whole antiserum |
| B1522 | Basal Medium Eagle With Earle′s salts and sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture |
| B1531 | Monoclonal Anti-Phosphotyrosine−Biotin antibody produced in mouse clone PT-66, purified immunoglobulin, buffered aqueous solution |
| B1532 | Resorufin benzyl ether CYP450 substrate |
| B1533 | Nalgene® centrifuge bottles, style 3120 nominal capacity 1000 mL, for IEC rotors |